Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 41, Issue 4, 1998, Pages 596-602

  Mehrian, Ruty ^a   Quismorio Jr , Francisco P ^a   Strassmann, Gideon ^a   Stimmler, Mary M ^a   Horwitz, David A ^a   Kitridou, Rodanthi C ^a   Gauderman, W James ^a   Morrison, John ^a   Brautbar, Chaim ^b   Jacob, Chaim O ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PROTEIN BCL 2;

ADULT; ALLELE; ARTICLE; ETHNOLOGY; FEMALE; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; APOPTOSIS; DATA INTERPRETATION, STATISTICAL; FAS LIGAND PROTEIN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; MEXICAN AMERICANS; ODDS RATIO; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0031926054     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2     Document Type: Article

References (30)

1. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
2. Rose LM, Lachman DS, Isenberg DA. Bcl-2 and Fas, molecules which influence apoptosis: a possible role in systemic lupus erythematosus? Autoimmunity 1994;17:271-8.
3. Nagata S, Golstein P. The Fas death factor. Science 1995;267: 1449-56.
4. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, et al. Fas (CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 1995;373:444-8.
5. Korsmeyer SJ. Bcl-2: a repressor of lymphocyte death. Immunol Today 1992;13:285-8.
6. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, et al. Enforced Bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A 1991;88:8661-5.
7. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
8. Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cell by induction of the Bcl-2 protein. J Clin Invest 1994;93:424-8.
9. Itoh K, Hirohata S. The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol 1995;154:4341-50.
10. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994;179:305-10.
11. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 1995;92:811-5.
12. Merriman TR, Todd JA. Genetics of autoimmune diseases. Curr Opin Immunol 1995;7:783-5.
13. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995;80:41-5.
14. Nistico L, Buzzetti R, Pritchard LE, van der Auwera B, Giovannini C, Bosi E, et al. The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Genet 1996;5:1075-80.
15. Marron MP, Raffel LJ, Gachon H-J, Jacob CO, Serrano-Rios M, Martinez MT, et al. Insulin-dependent diabetes mcllitus is associated with CTLA4 polymorphism in multiple ethnic groups. Hum Mol Genet 1997;6:1275-82.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res 1991;19:4018.
18. The Mouse Genome Data Base. Location of IL10 and BCL2 on mouse chromosome 1. [inquiry date: Feb 13, 1997]. URL: http:// www.informatics.JAX.org.
19. Eskadale J, Kude D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the flanking sequence. Immunogenetics 1997;46:120-8.
20. The Genome Database. The location of human BCL2. [inquiry date: Nov 20, 1993]. URL: http://www.bis.med.jhmi.edu.
21. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphism at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997;49:635-9.
22. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
23. Strasser A, O'Connor L, Huang DC, O'Reily LA, Stanley ML, Bath ML, et al. Lessons from Bcl-2 transgenic mice for immunology, cancer biology and cell death research. Behring Inst Mitt 1996;97:101-17.
24. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1423-30.
25. Gatenby PA, Irvine M. The Bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus. J Autoimmun 1994;7:623-31.
26. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995;181:839-44.
27. Taga K, Cherney B, Tosato G. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 1993;5:1599-608.
28. Taga K, Chretien J, Cherney B, Diaz L, Brown M, Tosato G. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 1994;94:251-60.
29. Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997;99:725-31.
30. Kotzin BL. Susceptibility loci for lupus: a guiding light from murine models? J Clin Invest 1997;99:557-8.